Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cognitive Behavioral Therapy for Depression in Parkinson's Disease
This study is enrolling participants by invitation only.
Sponsors and Collaborators: Oregon Health and Science University
National Parkinson Foundation
Information provided by: Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT00810628
  Purpose

The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD.

Target population is patients in the Movement Disorders Clinic at Oregon Health & Science University who have Parkinson's disease and mild to moderate depression.


Condition Intervention
Parkinson's Disease
Depression
Behavioral: Cognitive Behavioral Therapy

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease
MedlinePlus related topics: Depression Parkinson's Disease
U.S. FDA Resources
Study Type: Interventional
Study Design: Supportive Care, Open Label, Single Group Assignment
Official Title: Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping

Further study details as provided by Oregon Health and Science University:

Primary Outcome Measures:
  • To be developed, including change in CESD score [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 12
Study Start Date: January 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
All subjects in same investigative group with same CBT intervention.
Behavioral: Cognitive Behavioral Therapy
Individual interviews and group discussion/training.

  Eligibility

Ages Eligible for Study:   35 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parkinson's disease, mild to moderate depression, seen at Oregon Health & Science University

Exclusion Criteria:

  • Suicidal
  • Cognitive impairment with MOCA <26
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00810628

Locations
United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97239
Sponsors and Collaborators
Oregon Health and Science University
National Parkinson Foundation
Investigators
Principal Investigator: Julie H. Carter, MS Oregon Health and Science University
Principal Investigator: Kristine Hanna, PhD Oregon Health and Science University
  More Information

Publications:
Responsible Party: Oregon Health & Science University ( Julie Carter, MS, ANP )
Study ID Numbers: OHSUIRB4613
Study First Received: December 17, 2008
Last Updated: December 17, 2008
ClinicalTrials.gov Identifier: NCT00810628  
Health Authority: United States: Institutional Review Board

Keywords provided by Oregon Health and Science University:
Parkinson's disease
depression
Parkinson's disease with mild to moderate depression.

Study placed in the following topic categories:
Depression
Ganglion Cysts
Basal Ganglia Diseases
Central Nervous System Diseases
Depressive Disorder
Brain Diseases
Neurodegenerative Diseases
Behavioral Symptoms
Parkinson Disease
Mental Disorders
Movement Disorders
Mood Disorders
Parkinsonian Disorders

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009